| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18829563 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Horton HM, Bernett MJ, Pong E, et al.
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. [Journal Article]
Cancer Res 2008 Oct 1; 68(19):8049-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lefterova P, Märten A, Buttgereit P, et al.
Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity. [Journal Article]
J Immunother 2000 May-Jun; 23(3):304-10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Scheuermann RH, Racila E
CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. [Journal Article, Review]
Leuk Lymphoma 1995 Aug; 18(5-6):385-97.
Abstract | Full Citation | Find Related Articles | | Stavenhagen JB, Gorlatov S, Tuaillon N, et al.
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. [Journal Article]
Cancer Res 2007 Sep 15; 67(18):8882-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Law CL, Gordon KA, Collier J, et al.
Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40. [Journal Article]
Cancer Res 2005 Sep 15; 65(18):8331-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gidlöf C, Dohlsten M, Lando P, et al.
A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies. [Journal Article]
Blood 1997 Mar 15; 89(6):2089-97.
Abstract | Full Citation | Find Related Articles | | Niwa R, Shoji-Hosaka E, Sakurada M, et al.
Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. [Journal Article]
Cancer Res 2004 Mar 15; 64(6):2127-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | McEarchern JA, Oflazoglu E, Francisco L, et al.
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. [JOURNAL ARTICLE]
Blood 2006 Oct 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vuist WM, v Buitenen F, de Rie MA, et al.
Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model. [Journal Article]
Cancer Res 1989 Jul 15; 49(14):3783-8.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
